295 related articles for article (PubMed ID: 19276269)
21. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
22. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of INI1 in sporadic human brain tumors.
Weber M; Stockhammer F; Schmitz U; von Deimling A
Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819
[TBL] [Abstract][Full Text] [Related]
24. Array analysis and molecular studies of INI1 in an infant with deletion 22q13 (Phelan-McDermid syndrome) and atypical teratoid/rhabdoid tumor.
Sathyamoorthi S; Morales J; Bermudez J; McBride L; Luquette M; McGoey R; Oates N; Hales S; Biegel JA; Lacassie Y
Am J Med Genet A; 2009 May; 149A(5):1067-9. PubMed ID: 19334084
[No Abstract] [Full Text] [Related]
25. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
[TBL] [Abstract][Full Text] [Related]
26. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract][Full Text] [Related]
27. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
Boyd C; Smith MJ; Kluwe L; Balogh A; Maccollin M; Plotkin SR
Clin Genet; 2008 Oct; 74(4):358-66. PubMed ID: 18647326
[TBL] [Abstract][Full Text] [Related]
28. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
29. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
[TBL] [Abstract][Full Text] [Related]
31. Two single nucleotide polymorphisms of the hSNF5/INI1 gene.
Mine N; Bando K; Utada Y; Nagai H; Araki T; Emi M
J Hum Genet; 1999; 44(5):354-5. PubMed ID: 10496084
[TBL] [Abstract][Full Text] [Related]
32. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
[TBL] [Abstract][Full Text] [Related]
33. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
Raisanen J; Biegel JA; Hatanpaa KJ; Judkins A; White CL; Perry A
Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233
[TBL] [Abstract][Full Text] [Related]
35. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
[TBL] [Abstract][Full Text] [Related]
36. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
37. Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.
Misawa A; Hosoi H; Imoto I; Iehara T; Sugimoto T; Inazawa J
J Hum Genet; 2004; 49(10):586-589. PubMed ID: 15378398
[TBL] [Abstract][Full Text] [Related]
38. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
39. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
[TBL] [Abstract][Full Text] [Related]
40. A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.
Coccé MC; Lubieniecki F; Kordes U; Alderete D; Gallego MS
J Neurooncol; 2011 Aug; 104(1):375-80. PubMed ID: 21127945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
